Jessica Ferguson Toll

Dr. Jessica Ferguson Toll is a Clinical Assistant Professor in the Department of Medicine - Infectious Diseases at Stanford University. She specializes in treating immunocompromised patients, including those undergoing bone marrow or solid organ transplantation and those with malignancies on chemotherapy. Her academic appointments and clinical focus center on managing infections in immunocompromised hosts.

Dr. Ferguson completed her medical education at UCLA David Geffen School of Medicine (2015), followed by an internal medicine residency at Stanford University (2018) and a fellowship in Infectious Diseases with specialization in immunocompromised host care at Stanford (2021). She is board-certified in both Internal Medicine (2018) and Infectious Disease (2020).

Her research interests include perioperative outcomes in liver transplantation, post-transplant infections, SARS-CoV-2 pathogenesis in immunocompromised patients, and strategies to reduce antimicrobial resistance. She has contributed to studies on viral reactivation in autoimmune diseases and diagnostic challenges in transplant recipients.

Her recent publications analyze outcomes of limited sobriety liver transplant patients, CMV reactivation in renal transplant recipients, and the efficacy of combination antifungal therapies. She has also investigated SARS-CoV-2 transmission dynamics and vaccination responses in immunosuppressed populations.

Dr. Ferguson's clinical practice is based at the Stanford Infectious Disease Clinic in Palo Alto, CA. She actively collaborates on initiatives addressing infection prevention, transplant-related infections, and pandemic response strategies.